Aetna Enhances Oncology Care Accessibility with Expanded Authorization Bundles
Aetna®, a subsidiary of CVS Health®, is taking significant steps to improve healthcare access for cancer patients. Starting from September 1, 2026, Aetna is rolling out enhanced prior authorization bundles tailored for every type of cancer, aiming to alleviate the administrative load on healthcare providers and ensure quicker care for eligible Medicaid members. This initiative is a continuation of Aetna's commitment to enhance patient experiences by making the complex world of cancer treatment more straightforward.
Recent data indicates that nearly 25% of eligible members have already benefitted from these bundled prior authorizations. Traditionally, healthcare providers were required to submit separate prior authorizations for each treatment, a process that could become cumbersome and time-consuming. Aetna's innovative solution condenses these separate requests into one secure authorization process, streamlining access to a variety of treatments simultaneously. This includes not just the medical oncology services like chemotherapy and immunotherapy, but also essential imaging requirements such as MRIs and CT scans.
Katerina Guerraz, Aetna’s Chief Operating Officer and President of Medicaid, emphasizes the importance of this initiative. "A cancer diagnosis can be overwhelming for patients and families, and the care team should be focused on their patient, not paperwork. By approving a broader set of treatments and related services upfront, we're removing barriers that can delay care," she stated. This forward-thinking approach gives oncologists more flexibility in managing treatment plans as they evolve, thus allowing patients to focus on their health and recovery.
Healthcare providers have long reported that administrative tasks, particularly prior authorizations, significantly detract from the time they can spend on patient care. An Aetna Provider Survey highlighted that 74% of surveyed providers identified administrative burdens as a pressing concern. Furthermore, nearly a third indicated that managing prior authorizations was the largest contributing factor to this inefficiency. With the new bundled services, Aetna anticipates that medical professionals may save considerable time. Many respondents from the survey suggested that they could reclaim up to an hour a day through technology-driven solutions like these authorization bundles, which could enhance their ability to provide patient care.
Alongside the expansion for Medicaid members, there are plans in place to broaden eligibility for Medicare and Commercial members, set to be implemented in the first half of 2027. This anticipates a wider reach and adoption of the improved care access model, benefiting even more patients as Aetna continues to innovate in the healthcare space.
The newly implemented system is currently available for providers in select states including Oklahoma, Illinois, Maryland, New Jersey, Virginia, Florida, Kentucky, and West Virginia, who utilize Aetna's Eviti portal for prior authorizations. This is aimed at facilitating a smoother, more efficient experience for both healthcare providers and their patients, ultimately advancing Aetna's goal of improving healthcare delivery and patient outcomes.
As a leading company in health solutions, Aetna serves around 37 million individuals by providing a range of health insurance products and related services. With its dedication to simplifying healthcare, especially in oncology, Aetna remains at the forefront of innovations designed to connect people to better health.
For more information on Aetna’s services and initiatives in cancer care, healthcare providers and members can visit Aetna.com. This resource offers comprehensive insights into clinical practices, eligibility criteria, and participation opportunities in disease management programs, ensuring that both patients and providers are informed and empowered in their healthcare decisions.